Loading provider…
Loading provider…
Pediatric Hematology & Oncology Physician in Los Angeles, CA
NPI: 1235391996Primary Practice Location
CHILDREN'S HOSP OF LOS ANGELES
4650 W Sunset Blvd, Los Angeles, CA
Primary Employer
Children's Hospital Los Angeles Medical Group, Inc.
chla.org
HQ Phone
Get MD Nathan's Phone Numberphone_androidMobile
Get MD Nathan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
CA State Medical License
CA State Medical License
2004 - 2026
MA State Medical License
2009 - 2014

American Board of Pediatrics
Pediatrics

American Board of Pediatrics
Pediatric Hematology-Oncology
Brigham and Women's Hospital/Dana-Farber Cancer Institute/Harvard Medical School
Fellowship • Pediatric Neuro-Oncology
2009 - 2010
Children's Hospital Los Angeles
Fellowship • Pediatric Hematology/Oncology
2006 - 2009
Residency • Pediatrics
2002 - 2005
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 2002
Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor
Authors: Benita Tamrazi, Jennifer Cotter, Debra Hawes
Journal: J Neurosurg Pediatr
Publication Date: 2017-04-07
Authors: Sarah Leary, George Jallo, Tadanori Tomita, Karen Wright, Lissa Baird, Dolly Aguilera, Sandeep Sood, Melanie Comito, Liliana Goumnerova, Arthur Dipatri, Sridharan Gururangan, Michael Handler, David Harter, Peter Manley, David Limbrick, Stewart Goldman, Samuel Browd, Sharon Gardner, Mark Dias,
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, RADIATION: Radiation Therapy, DRUG: Trametinib Dimethyl Sulfoxide, PROCEDURE: Lumbar Puncture, DRUG: Dabrafenib Mesylate
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, PROCEDURE: X-Ray Imaging, DRUG: Savolitinib
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, PROCEDURE: Magnetic Resonance Spectroscopic Imaging, PROCEDURE: Diffusion Weighted Imaging, PROCEDURE: Diffusion Tensor Imaging, PROCEDURE: Conventional Magnetic Resonance Imaging, PROCEDURE: Dynamic Contrast-enhanced MR Perfusion, PROCEDURE: Dynamic Susceptibility Contrast-Perfusion-Weighted Imaging